With a new CEO and Brazilian distributor, the Finnish firm is looking at additional Latin American and Asian markets and increased support for COVID-19 sequencing.
Osang previously granted nonexclusive US distribution rights to the PCR-based test to SG Blocks and has a manufacturing arrangement for the test with Nexus Dx.
The firm said that Microbix COVID-variant quality assessment products will monitor the workflow accuracy and laboratory testing performance of Seegene variant assays.
Binx Health said the initial distribution of its platform will be to settings certified to perform moderate- or high-complexity diagnostic tests under CLIA.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
